Monthly Pulse Methylprednisolone Therapy is Effective in Preventing Permanent Disease Progression in Secondary Progressive Multiple Sclerosis

Creative Commons License

ÖZAKBAŞ S., Cinar B. P., Oz D., Kosehasanogullari G., Kursun B. B., Kahraman T.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, cilt.56, sa.2, ss.115-118, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 56 Sayı: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5152/npa.2017.19339
  • Dergi Adı: NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.115-118
  • Anahtar Kelimeler: Secondary progressive multiple sclerosis, monthly methylprednisolone treatment, disease progression, IV METHYLPREDNISOLONE, TRIAL
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Introduction: Secondary progressive multiple sclerosis (SPMS) is the phase in which disability continues to worsen with or without accompanying attacks. Monthly methylprednisolone pulse therapy can be used in the secondary progressive phase. The purpose of the present study was to evaluate the effects of methylprednisolone pulse therapy on the basis of clinical and MRI parameters in patients with SPMS.